{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:04:23Z","timestamp":1792677863020,"version":"4.5.0"},"reference-count":37,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/100002554","name":"Aids Healthcare Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,4,30]]},"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Isoniazid preventive therapy (IPT), for people living with HIV (PLHIV) is the proven and recommended intervention to avert tuberculosis (TB). In 2015, Nepal implemented 6\u2009months of IPT for all PLHIV registered for HIV care in antiretroviral therapy (ART) centres. After programmatic implementation, there has been no systematic assessment of IPT initiation and completion rates among PLHIV. We aimed to assess IPT initiation and completion rates in the Far-Western Region (FWR) of Nepal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using secondary data extracted from registers maintained at ART centres.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>All 11 ART centres in the FWR of Nepal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>All PLHIV registered for care between January 2016 and December 2017 in 11 ART centres.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary outcome measures<\/jats:title>\n                    <jats:p>IPT initiation and completion rates were summarised as percentages with 95% CI. Independent association between patient characteristics and non-initiation of IPT was assessed using cluster-adjusted generalised linear model (log binomial regression) and adjusted relative risk (RR) with 95%\u2009CI was calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Of the 492 PLHIV included, 477 (97.0%) did not have active TB at registration. Among 477 without active TB, 141 (29.8%, 95%\u2009CI 25.7% to 34.1%) had been initiated on IPT and 85 (17.8%) were initiated within 3\u2009months of registration. Of 141 initiated on IPT, 133 (94.3%, 95%\u2009CI 89.1% to 97.5%) had completed 6\u2009months of IPT. Being more than 60 years of age (RR-1.3, 95%\u2009CI 1.1 to 1.7), migrant worker (RR-1.3, 95%\u2009CI 1.1 to 1.4) and not being initiated on ART (RR-1.4, 95%\u2009CI 1.1 to 1.8) were significantly associated with IPT initiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In FWR of Nepal, three out of 10 eligible PLHIV had received IPT. Among those who have received IPT, the completion rate was good. The HIV care programme needs to explore the potential reasons for this low coverage and take context specific corrective action to fix this gap.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-029058","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T06:34:23Z","timestamp":1559198063000},"page":"e029058","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study"],"prefix":"10.1136","volume":"9","author":[{"given":"Govinda Prasad","family":"Dhungana","sequence":"first","affiliation":[{"name":"Faculty of Science and Technology, Far Western University, Mahendranagar, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pruthu","family":"Thekkur","sequence":"additional","affiliation":[{"name":"Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, Paris, France"},{"name":"Centre for Operational Research, The Union South-East Asia Office, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palanivel","family":"Chinnakali","sequence":"additional","affiliation":[{"name":"Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Bhatta","sequence":"additional","affiliation":[{"name":"National Center for AIDS and STD Control, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basudev","family":"Pandey","sequence":"additional","affiliation":[{"name":"Sukraraj Tropical and Infectious Disease Hospital, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hong","family":"Zhang","sequence":"additional","affiliation":[{"name":"International Centre for Reproductive Health (ICRH), Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Gent, Belgium"},{"name":"Research Laboratory for Human Reproduction, Faculty of Medicine, School of Public Health, Universit\u00e9 Libre de Bruxelles (ULB), Bruxelles, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"2025121223124978000_9.5.e029058.1","unstructured":"World Health Organization. Global Tuberculosis Report 2018. Geneva, Switzerland, 2018:1\u2013231."},{"key":"2025121223124978000_9.5.e029058.2","unstructured":"Joint United Nations Programme on HIV\/AIDS. Global HIV & AIDS statistics \u2014 2018 fact sheet. 2018 http:\/\/www.unaids.org\/en\/resources\/fact-sheet (Cited 6 Sep 2018)."},{"key":"2025121223124978000_9.5.e029058.3","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2nd edn. Geneva, Switzerland, 2016."},{"key":"2025121223124978000_9.5.e029058.4","unstructured":"World Health Organization. WHO policy on collaborative TB\/HIV activities-Guidelines for national programmes and other stakeholders. Geneva, Switzerland, 2012."},{"key":"2025121223124978000_9.5.e029058.5","unstructured":"World Health Organization. Latent tuberculosis infection: Updated and consolidated guidelines for programmatic management. Geneva, Switzerland, 2018."},{"key":"2025121223124978000_9.5.e029058.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507198"},{"key":"2025121223124978000_9.5.e029058.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506816"},{"key":"2025121223124978000_9.5.e029058.8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5588\/pha.16.0053","article-title":"Scale-up of ART in Malawi has reduced case notification rates in HIV-positive and HIV-negative tuberculosis","volume":"6","author":"Kanyerere","year":"2016","journal-title":"Public Health Action"},{"key":"2025121223124978000_9.5.e029058.9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/tmi.12630","article-title":"The rise and fall of tuberculosis in Malawi: associations with HIV infection and antiretroviral therapy","volume":"21","author":"Kanyerere","year":"2016","journal-title":"Trop Med Int Health"},{"key":"2025121223124978000_9.5.e029058.10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5588\/pha.16.0029","article-title":"Declining tuberculosis case notification rates with the scale-up of antiretroviral therapy in Zimbabwe","volume":"6","author":"Takarinda","year":"2016","journal-title":"Public Health Action"},{"key":"2025121223124978000_9.5.e029058.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099880","article-title":"Comparison of trends in tuberculosis incidence among adults living with HIV and adults without HIV--Kenya, 1998-2012","volume":"9","author":"Yuen","year":"2014","journal-title":"PLoS One"},{"key":"2025121223124978000_9.5.e029058.12","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1016\/S2352-3018(15)00063-6","article-title":"Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern Ireland","volume":"2","author":"Gupta","year":"2015","journal-title":"Lancet HIV"},{"key":"2025121223124978000_9.5.e029058.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034156","article-title":"Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community","volume":"7","author":"Gupta","year":"2012","journal-title":"PLoS One"},{"key":"2025121223124978000_9.5.e029058.14","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"1","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121223124978000_9.5.e029058.15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/INF.0000000000001879","article-title":"Isoniazid for the Prevention of Tuberculosis in HIV-Infected Children","volume":"37","author":"Charan","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"2025121223124978000_9.5.e029058.16","first-page":"CD006418","article-title":"Isoniazid for preventing tuberculosis in HIV-infected children","volume":"8","author":"Zunza","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121223124978000_9.5.e029058.17","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328327964f"},{"key":"2025121223124978000_9.5.e029058.18","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328216f441"},{"key":"2025121223124978000_9.5.e029058.19","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1016\/S2214-109X(17)30372-8","article-title":"Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial","volume":"5","author":"Badje","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2025121223124978000_9.5.e029058.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104557","article-title":"Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia","volume":"9","author":"Yirdaw","year":"2014","journal-title":"PLoS One"},{"key":"2025121223124978000_9.5.e029058.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60162-8"},{"key":"2025121223124978000_9.5.e029058.22","unstructured":"World Health Organization. Interim Policy on Collaborative TB\/HIV Activities. Geneva, Switzerland, 2004."},{"key":"2025121223124978000_9.5.e029058.23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/PPA.S131314","article-title":"Self-reported adherence and associated factors to isoniazid preventive therapy for latent tuberculosis among people living with HIV\/AIDS at health centers in Gondar town, North West Ethiopia","volume":"11","author":"Ayele","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"2025121223124978000_9.5.e029058.24","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.5588\/ijtld.15.0805","article-title":"Predictors of adherence to isoniazid preventive therapy in people living with HIV in Ethiopia","volume":"20","author":"Ayele","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025121223124978000_9.5.e029058.25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5588\/ijtld.16.0836","article-title":"Predictors of isoniazid preventive therapy completion among adults newly diagnosed with HIV in rural Malawi","volume":"22","author":"Little","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025121223124978000_9.5.e029058.26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5588\/pha.16.0102","article-title":"Routine implementation of isoniazid preventive therapy in HIV-infected patients in seven pilot sites in Zimbabwe","volume":"7","author":"Takarinda","year":"2017","journal-title":"Public Health Action"},{"key":"2025121223124978000_9.5.e029058.27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5588\/pha.16.0012","article-title":"Dotting the Three I\u2019s for collaborative TB-HIV activities: evaluation of a pilot programme in Kathmandu, Nepal","volume":"6","author":"Sah","year":"2016","journal-title":"Public Health Action"},{"key":"2025121223124978000_9.5.e029058.28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5588\/pha.17.0087","article-title":"IPT during HIV treatment in Myanmar: high rates of coverage, completion and drug adherence","volume":"8","author":"Ousley","year":"2018","journal-title":"Public Health Action"},{"key":"2025121223124978000_9.5.e029058.29","unstructured":"Ministry of Health & Population, Department of Health Services, National Tuberculosis Centre. National Tuberculosis Program Nepal Annual Report-2017 [Internet]. Thimi, Bhaktapur. 2018."},{"key":"2025121223124978000_9.5.e029058.30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3126\/saarctb.v12i1.15939","article-title":"Surveillance of HIV Infection among Patients with Tuberculosis in Nepal","volume":"12","author":"Sah","year":"2016","journal-title":"SAARC Journal of Tuberculosis, Lung Diseases and HIV\/AIDS"},{"key":"2025121223124978000_9.5.e029058.31","unstructured":"Department of International Development. Regional Dimensions of Poverty and Vulnerability in Nepal. 2013 https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/209483\/Regional-dimension-poverty-nepal-background.pdf."},{"key":"2025121223124978000_9.5.e029058.32","unstructured":"Central Bureau of Statistics. National population and housing census 2011. Vol. 1 [Internet]. Kathmandu, Nepal. 2012 https:\/\/unstats.un.org\/unsd\/demographic\/sources\/census\/wphc\/Nepal\/Nepal-Census-2011-Vol1.pdf."},{"key":"2025121223124978000_9.5.e029058.33","unstructured":"Ministry of Health, New ERA, The DHS Program. Nepal Demographic and Health Survey 2016 [Internet]. Kathmandu, Nepal. 2017 https:\/\/dhsprogram.com\/pubs\/pdf\/FR336\/FR336.pdf."},{"key":"2025121223124978000_9.5.e029058.34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-310"},{"key":"2025121223124978000_9.5.e029058.35","unstructured":"National Centre for AIDS and STD Control. National HIV Testing and Treatment Guidelines 2017,\u00a0Kathmandu, Nepal. 2017 https:\/\/www.aidsdatahub.org\/sites\/default\/files\/toolandguide\/document\/National_HIV_testing_and_Treatment_Guidelines_2017.pdf."},{"key":"2025121223124978000_9.5.e029058.36","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/trv074"},{"key":"2025121223124978000_9.5.e029058.37","unstructured":"World Health Organization. Global Tuberculosis Report 2017. Geneva, Switzerland, 2017."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-029058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:13:01Z","timestamp":1765609981000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-029058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,29]]},"published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1136\/bmjopen-2019-029058"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-029058","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}